A Phase 3, Placebo-controlled, Double-blind Study Assessing Rocatinlimab in Prurigo Nodularis

Clinical trial NCT06527404 · TERMINATED

Trial details

NCT number: NCT06527404
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prurigo Nodularis

Start date: 2024-07-18
Primary completion: 2026-04-17
Enrollment: 469

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.